Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
Eli Lilly said Wednesday it will build three manufacturing plants in the United States to make the key raw ingredients in its ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing ...
Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...
Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...
Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is ...
The pharmaceutical firm is growing its presence across three states, creating 3,000 jobs.
The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...
Eli Lilly and Company said Wednesday they plan to build new pharmaceutical manufacturing sites in the United States.
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results